MwanzoRLF • SWX
add
RELIEF THERAPEUTICS Holding SA
Bei iliyotangulia
CHF 3.84
Bei za siku
CHF 3.78 - CHF 3.96
Bei za mwaka
CHF 1.06 - CHF 7.60
Thamani ya kampuni katika soko
55.60M CHF
Wastani wa hisa zilizouzwa
elfu 51.73
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
SWX
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CHF) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.83M | 87.03% |
Matumizi ya uendeshaji wa biashara | 4.04M | -41.31% |
Mapato halisi | -2.28M | 91.93% |
Kiwango cha faida halisi | -80.60 | 95.69% |
Mapato kwa kila hisa | — | — |
EBITDA | -1.27M | 74.88% |
Asilimia ya kodi ya mapato | -14.01% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CHF) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 10.73M | -16.20% |
Jumla ya mali | 70.92M | -43.61% |
Jumla ya dhima | 21.65M | -31.07% |
Jumla ya hisa | 49.27M | — |
hisa zilizosalia | 12.55M | — |
Uwiano wa bei na thamani | 0.98 | — |
Faida inayotokana na mali | -7.01% | — |
Faida inayotokana mtaji | -9.62% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CHF) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -2.28M | 91.93% |
Pesa kutokana na shughuli | -1.58M | 69.75% |
Pesa kutokana na uwekezaji | elfu -3.50 | 96.82% |
Pesa kutokana na ufadhili | elfu -308.00 | -114.76% |
Mabadiliko halisi ya pesa taslimu | -1.91M | 40.61% |
Mtiririko huru wa pesa | elfu -635.56 | 75.84% |
Kuhusu
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG and listed on the SIX Swiss Exchange in 2016. Wikipedia
Ilianzishwa
2013
Tovuti
Wafanyakazi
36
